144 related articles for article (PubMed ID: 7798645)
1. Neurofibromatosis 2 and neurilemmomatosis gene are identical.
Honda M; Arai E; Sawada S; Ohta A; Niimura M
J Invest Dermatol; 1995 Jan; 104(1):74-7. PubMed ID: 7798645
[TBL] [Abstract][Full Text] [Related]
2. Neurilemmomatosis, NF2, and juvenile xanthogranuloma.
Iyengar V; Golomb CA; Schachner L
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):831-4. PubMed ID: 9810909
[TBL] [Abstract][Full Text] [Related]
3. Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis.
Jacoby LB; MacCollin M; Parry DM; Kluwe L; Lynch J; Jones D; Gusella JF
Neurogenetics; 1999 Apr; 2(2):101-8. PubMed ID: 10369886
[TBL] [Abstract][Full Text] [Related]
4. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
[TBL] [Abstract][Full Text] [Related]
5. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
[TBL] [Abstract][Full Text] [Related]
6. Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF2.
Arai E; Tokino T; Imai T; Inazawa J; Ikeuchi T; Tonomura A; Nakamura Y
Genes Chromosomes Cancer; 1993 Apr; 6(4):235-8. PubMed ID: 7685627
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the translocation breakpoint on chromosome 22q12.2 in a patient with neurofibromatosis type 2 (NF2).
Arai E; Ikeuchi T; Nakamura Y
Hum Mol Genet; 1994 Jun; 3(6):937-9. PubMed ID: 7951241
[TBL] [Abstract][Full Text] [Related]
8. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
9. Analysis of mutations in the SCH gene in schwannomas.
Bijlsma EK; Merel P; Bosch DA; Westerveld A; Delattre O; Thomas G; Hulsebos TJ
Genes Chromosomes Cancer; 1994 Sep; 11(1):7-14. PubMed ID: 7529050
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2.
Kehrer-Sawatzki H; Udart M; Krone W; Baden R; Fahsold R; Thomas G; Schmucker B; Assum G
Hum Genet; 1997 Jul; 100(1):67-74. PubMed ID: 9225971
[TBL] [Abstract][Full Text] [Related]
11. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
12. Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH).
Antinheimo J; Sallinen SL; Sallinen P; Haapasalo H; Helin H; Horelli-Kuitunen N; Wessman M; Sainio M; Jääskeläinen J; Carpén O
Acta Neurochir (Wien); 2000; 142(10):1099-104; discussion 1104-5. PubMed ID: 11129530
[TBL] [Abstract][Full Text] [Related]
13. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
Buckley PG; Mantripragada KK; Díaz de Ståhl T; Piotrowski A; Hansson CM; Kiss H; Vetrie D; Ernberg IT; Nordenskjöld M; Bolund L; Sainio M; Rouleau GA; Niimura M; Wallace AJ; Evans DG; Grigelionis G; Menzel U; Dumanski JP
Hum Mutat; 2005 Dec; 26(6):540-9. PubMed ID: 16287142
[TBL] [Abstract][Full Text] [Related]
14. [Neurilemmomatosis--a sporadic and familial cases].
Sasaki T; Ono H; Nakajima H; Kameda Y
Nihon Hifuka Gakkai Zasshi; 1991 Jun; 101(7):727-33. PubMed ID: 1942581
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of chromosome 22 deletions in schwannomas.
Bijlsma EK; Brouwer-Mladin R; Bosch DA; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1992 Oct; 5(3):201-5. PubMed ID: 1384671
[TBL] [Abstract][Full Text] [Related]
16. Progress toward the isolation and characterization of the genes causing neurofibromatosis.
Menon AG; Gusella JF; Seizinger BR
Brain Pathol; 1990 Sep; 1(1):33-40. PubMed ID: 1669691
[TBL] [Abstract][Full Text] [Related]
17. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis type 2 appears to be a genetically homogeneous disease.
Narod SA; Parry DM; Parboosingh J; Lenoir GM; Ruttledge M; Fischer G; Eldridge R; Martuza RL; Frontali M; Haines J
Am J Hum Genet; 1992 Sep; 51(3):486-96. PubMed ID: 1496982
[TBL] [Abstract][Full Text] [Related]
19. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.
Kluwe L; Friedrich RE; Hagel C; Lindenau M; Mautner VF
J Invest Dermatol; 2000 May; 114(5):1017-21. PubMed ID: 10771486
[TBL] [Abstract][Full Text] [Related]
20. The parental origin of new mutations in neurofibromatosis 2.
Kluwe L; Mautner V; Parry DM; Jacoby LB; Baser M; Gusella J; Davis K; Stavrou D; MacCollin M
Neurogenetics; 2000 Sep; 3(1):17-24. PubMed ID: 11085592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
